330 related articles for article (PubMed ID: 27075671)
1. Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.
Kharytonchyk S; King SR; Ndongmo CB; Stilger KL; An W; Telesnitsky A
J Mol Biol; 2016 Jun; 428(11):2275-2288. PubMed ID: 27075671
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
3. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
[TBL] [Abstract][Full Text] [Related]
4. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
Miranda LR; Götte M; Liang F; Kuritzkes DR
Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.
Arion D; Kaushik N; McCormick S; Borkow G; Parniak MA
Biochemistry; 1998 Nov; 37(45):15908-17. PubMed ID: 9843396
[TBL] [Abstract][Full Text] [Related]
6. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
Bakhanashvili M
Oncogene; 2001 Nov; 20(52):7635-44. PubMed ID: 11753641
[TBL] [Abstract][Full Text] [Related]
7. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
Kerr SG; Anderson KS
Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
[TBL] [Abstract][Full Text] [Related]
8. Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
Álvarez M; Nevot M; Mendieta J; Martínez MA; Menéndez-Arias L
J Biol Chem; 2018 Feb; 293(7):2247-2259. PubMed ID: 29275329
[TBL] [Abstract][Full Text] [Related]
9. The interaction of the reverse transcriptase of human immunodeficiency virus type 1 with 3'-terminally mispaired DNA.
Bakhanashvili M; Hizi A
Arch Biochem Biophys; 1996 Oct; 334(1):89-96. PubMed ID: 8837743
[TBL] [Abstract][Full Text] [Related]
10. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
Canard B; Sarfati SR; Richardson CC
J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
[TBL] [Abstract][Full Text] [Related]
11. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
Brehm JH; Koontz D; Meteer JD; Pathak V; Sluis-Cremer N; Mellors JW
J Virol; 2007 Aug; 81(15):7852-9. PubMed ID: 17507476
[TBL] [Abstract][Full Text] [Related]
12. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.
Krebs R; Immendörfer U; Thrall SH; Wöhrl BM; Goody RS
Biochemistry; 1997 Aug; 36(33):10292-300. PubMed ID: 9254628
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein.
Bampi C; Bibillo A; Wendeler M; Divita G; Gorelick RJ; Le Grice SF; Darlix JL
J Biol Chem; 2006 Apr; 281(17):11736-43. PubMed ID: 16500895
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency.
Nikolenko GN; Svarovskaia ES; Delviks KA; Pathak VK
J Virol; 2004 Aug; 78(16):8761-70. PubMed ID: 15280484
[TBL] [Abstract][Full Text] [Related]
15. Mechanism by which phosphonoformic acid resistance mutations restore 3'-azido-3'-deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase.
Arion D; Sluis-Cremer N; Parniak MA
J Biol Chem; 2000 Mar; 275(13):9251-5. PubMed ID: 10734063
[TBL] [Abstract][Full Text] [Related]
16. Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.
Isaguliants MG; Belikov SV; Starodubova ES; Gizatullin RZ; Rollman E; Zuber B; Zuber AK; Grishchenko OI; Rytting AS; Källander CF; Kochetkov SN; Karpov VL; Wahren B
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):191-201. PubMed ID: 15018707
[TBL] [Abstract][Full Text] [Related]
17. Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies.
Mansky LM; Pearl DK; Gajary LC
J Virol; 2002 Sep; 76(18):9253-9. PubMed ID: 12186909
[TBL] [Abstract][Full Text] [Related]
18. Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication.
Caliendo AM; Savara A; An D; DeVore K; Kaplan JC; D'Aquila RT
J Virol; 1996 Apr; 70(4):2146-53. PubMed ID: 8642636
[TBL] [Abstract][Full Text] [Related]
19. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
Ueno T; Mitsuya H
Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
[TBL] [Abstract][Full Text] [Related]
20. Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.
Imamichi T; Berg SC; Imamichi H; Lopez JC; Metcalf JA; Falloon J; Lane HC
J Virol; 2000 Dec; 74(23):10958-64. PubMed ID: 11069990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]